Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

被引：0

作者：

Shimokawa, T. ^{[1
]}

Nakamura, Y. ^{[1
]}

Iwasawa, S. ^{[2
]}

Miyazaki, K. ^{[3
]}

Yamanaka, T. ^{[4
]}

Takiguchi, Y. ^{[2
]}

Okamoto, H. ^{[1
]}

机构：

[1] Yokohama Municipal CitizenS Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan

[2] Chiba Univ Hosp, Chiba, Japan

[3] Yokohama Municipal CitizenS Hosp, Yokohama, Kanagawa, Japan

[4] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan

来源：

关键词：

nivolumab plus docetaxel; non-small cell lung cancer;

D O I：

10.1016/j.jtho.2017.11.101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.07-042

引用

页码：S2431 / S2431

页数：1